Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2004
07/14/2004EP1436283A1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
07/14/2004EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors
07/14/2004EP1436266A2 Methods and compositions of novel triazine compounds
07/14/2004EP1436265A2 Chemical compounds
07/14/2004EP1436259A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
07/14/2004EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications
07/14/2004EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity
07/14/2004EP1435947A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
07/14/2004EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
07/14/2004EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
07/14/2004EP1037887B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
07/14/2004CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer
07/14/2004CN1513171A Optical data carrier containing dye in the information layer as light-absorbing compound
07/14/2004CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound
07/14/2004CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
07/14/2004CN1511830A Compound used as antiphlogistic
07/14/2004CN1157390C Indole derivant
07/14/2004CN1157386C Trisubstituted 1,3,5-triazine derivatives for treatment by HIV infections
07/14/2004CN1157382C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds
07/13/2004US6762226 Photostability; heat and oxidation resistance
07/13/2004US6762197 Fungicides
07/13/2004US6762194 Quinolinone derivatives
07/13/2004US6762189 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives
07/13/2004US6762188 Inhibiting thymidylate synthase; colon, breast or lung carcinoma
07/13/2004US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases
07/13/2004US6762180 Substituted indolines which inhibit receptor tyrosine kinases
07/13/2004CA2313106C Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents
07/13/2004CA2272690C Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
07/08/2004WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
07/08/2004WO2004056807A1 Pyrimidine derivatives for the treatment of abnormal cell growth
07/08/2004WO2004056806A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases
07/08/2004WO2004056786A2 Pyrimidine derivates for the treatment of abnormal cell growth
07/08/2004WO2004056785A2 Uracils having a herbicidal activity
07/08/2004WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments
07/08/2004WO2004056782A1 Pyrazole compounds
07/08/2004WO2004056766A1 Inhibitors of tace
07/08/2004WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders
07/08/2004WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
07/08/2004WO2004056347A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
07/08/2004WO2004037171A3 Mitotic kinesin inhibitors
07/08/2004WO2004022060A3 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
07/08/2004WO2003106628A3 Benzodiazepine inhibitors of mitochondial f¿1<f¿0? atp hydrolase and methods of inhibiting f¿1?f¿0? atp hydrolase
07/08/2004WO2003103663A3 Substituted pyrrolines as kinase inhibitors
07/08/2004WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism
07/08/2004US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome
07/08/2004US20040133008 Amide compounds
07/08/2004US20040133002 For therapy of disorders including those in which the inhibition of reverse transcriptase is implicated, such as Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS)
07/08/2004US20040132981 modified ligands that bind irreversibly to their cognate receptors; assay for investigating protein function and as drugs for more effectively inhibiting or stimulating cognate receptor function
07/08/2004US20040132809 Cell adhesion inhibitors
07/08/2004US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles
07/08/2004US20040132799 Aminoalkoxyindoles and methods of use
07/08/2004US20040132794 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
07/08/2004US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain.
07/08/2004US20040132781 Pyrazole compounds useful as protein kinase inhibitors
07/08/2004US20040132777 Aryl substituted benzimidazoles and their use as sodium channel blockers
07/08/2004US20040132755 Isoxazoles and uses thereof
07/08/2004US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia.
07/08/2004US20040132746 2-substituted 4-pyrrolyl-pyrimidines, e.g., 2-[N-(phenyl)]-4-(2,4-dimethylpyrrol-3-yl)pyrimidineamines in which the phenyl group is 2-, 3-, 4-or 5-substituted by at least one of F, NH2, NO2, OH, Cl, Br, I, CN, CH2OH, CF3 or OMe.
07/08/2004US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
07/08/2004US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease
07/08/2004US20040132733 Novel quinoxalinone derivatives as bradykinin B1 antagonists
07/08/2004US20040132727 Quinoline and quinazoline derivatives and drugs containing the same
07/08/2004US20040132721 Treatment of airway disorders
07/08/2004US20040132710 Lactams as tachkinin antagonists
07/08/2004US20040132619 Activity; crop compatibility; broad spectrum; cereals
07/08/2004US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof
07/08/2004DE10257358A1 Substituierte Pyrrole Substituted pyrroles
07/08/2004DE10237723A1 Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie Use of IkappaB kinase inhibitors in the treatment of pain
07/08/2004CA2510850A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
07/08/2004CA2510848A1 Pyrimidine derivates for the treatment of abnormal cell growth
07/08/2004CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions
07/08/2004CA2510069A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
07/08/2004CA2509403A1 Pyrazole compounds
07/08/2004CA2506826A1 Uracils having a herbicidal activity
07/07/2004EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
07/07/2004EP1434774A1 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
07/07/2004EP1434773A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
07/07/2004EP1434772A1 Compounds and methods
07/07/2004EP1434763A2 Beta-lactamyl vasopressin v1a antagonists
07/07/2004EP1434579A1 Imidazole derivatives as antiinflammatory agents
07/07/2004EP1401431A4 Human growth hormone antagonists
07/07/2004EP1218359B1 Piperazine compounds as tachykinins antagonists
07/07/2004CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor
07/07/2004CN1511143A Herbicidal substituted benzoylpyrazoles
07/07/2004CN1510034A Indazole compound, preparing method thereof and medicine composition containing the same
07/07/2004CN1510031A Ester compounds of bezimidazole and their preparations and uses in preparation of medicinal compound
07/07/2004CN1509713A Indole derivative use as 5HT1 antagonist agent
07/07/2004CN1156834C 光学记录介质 The optical recording medium
07/07/2004CN1156452C Compound as anti-inflammatory agent
07/07/2004CN1156445C Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives
07/06/2004US6759511 Compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same
07/06/2004US6759429 Having transforming growth factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues
07/06/2004US6759426 3-(Imidazolyl)-2-aminopropanoic acids
07/06/2004US6759425 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
07/06/2004US6759415 Affinity with subtypes of somatostatin receptors
07/06/2004US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
07/06/2004US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease
07/01/2004WO2004055009A1 Novel compounds having selective inhibiting efect at gsk3
07/01/2004WO2004055008A1 Compounds, compositions and methods